The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

BACKGROUND: The aim of the present study was to investigate the association between matrix metalloproteinase-9 (MMP-9) expression with BRAF V600E mutation and clinicopathological features, in Iranian papillary thyroid cancer (PTC) patients. METHODS: In total, 90 participants including 60 PTC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarkesh, Maryam, Zadeh-Vakili, Azita, Akbarzadeh, Mahdi, Fanaei, S. Ahmad, Hedayati, Mehdi, Azizi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276227/
https://www.ncbi.nlm.nih.gov/pubmed/30509240
http://dx.doi.org/10.1186/s12885-018-5112-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276227/
https://www.ncbi.nlm.nih.gov/pubmed/30509240
http://dx.doi.org/10.1186/s12885-018-5112-0

Ejemplares similares